CAC Software vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by Imbio

AI Verdict

Tool A focuses on quantifying coronary artery calcification from non-contrast chest CTs to assess coronary artery disease risk. In contrast, Tool B measures right and left ventricular diameters from CTPA scans to aid in risk stratification for pulmonary conditions such as pulmonary embolism. While both are AI-powered cardiology imaging tools from the same vendor, they serve different clinical purposes and analyze distinct anatomical features from different types of scans.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary objective is to automatically quantify coronary artery calcification from non-contrast chest CT scans. This tool is ideal for radiologists and cardiologists focused on assessing a patient's risk for coronary artery disease by providing Agatston scores, arterial age, and detailed 3D visualizations.

View CAC Software →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if you need an AI-powered solution to automatically measure right and left ventricular diameters from CTPA scans. This tool is best suited for aiding in risk stratification for pulmonary conditions, such as pulmonary embolism, by quickly calculating and reporting the crucial RV/LV ratio.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software Imbio RV/LV Software
Deployment Cloud-based (SaaS), integrates with PACS Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27]
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize fully automated workflows and seamless integration into existing clinical environments. Tool A integrates into existing DICOM viewing workflows and runs automatically with no user intervention. Similarly, Tool B offers a fully automated workflow with no user intervention required after scan completion and integrates with standard reading environments (PACS). Both are designed for minimal user input and ease of use within a radiological workflow.

Clinical Value

Tie

Both tools provide critical quantitative data for risk stratification in distinct, yet equally important, clinical areas. Tool A quantifies coronary artery calcification, a key biomarker for cardiovascular disease risk. Tool B measures RV/LV ratios for risk stratification in pulmonary conditions like pulmonary embolism, a vital metric for patient management. Each offers high clinical utility by providing objective measurements that aid in significant medical decision-making.

Pricing & Value

Imbio RV/LV Software

Tool B offers more transparency regarding its pricing model, stating it is subscription-based and determined by the number of analyses or installations. In contrast, Tool A only indicates 'contact for pricing.' This greater clarity from Tool B allows potential customers to better understand the cost structure upfront.

Enterprise Readiness

Imbio RV/LV Software

While both tools are FDA cleared, HIPAA compliant, and offer flexible deployment options (cloud, on-premise, partner platforms), Tool B provides slightly more detail. It explicitly mentions 'third-party hipaa compliant certified by compliancy group' and lists a broader range of specific partner platforms, suggesting a more extensively validated and integrated enterprise solution.

Innovation

Tie

Both tools demonstrate innovation by leveraging advanced AI and deep learning algorithms for automated medical image analysis. Tool A uses deep learning for coronary artery calcification quantification and 3D visualizations, while Tool B employs an AI algorithm for automated ventricular measurement. Neither presents a unique technological breakthrough that significantly surpasses the other in terms of innovative approach within the AI-powered medical imaging space.

Support & Docs

Tie

As both tools are products of Imbio, they benefit from the same company-wide customer support and documentation infrastructure. Imbio offers 24/7/365 support via email and website tickets, phone support during business hours, and provides user manuals and FAQs for its products. There is no indication that one product receives superior support or documentation over the other.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software Imbio RV/LV Software
Name CAC Software Imbio RV/LV Software
Company Imbio Imbio
Description Automated image post-processing algorithms to determine location and calculate amount of calcification within coronary arteries from non-contrast chest CT. AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism.
Key Features Automated image post-processing for coronary artery calcification; Quantification of calcification within coronary arteries; Outputs Agatston score, arterial age, calcified lesion mass and volume; Provides 3D visualizations and annotated images; Non-invasive analysis from non-contrast chest CT scans; Integrates into existing DICOM viewing workflow; Supports risk assessment for coronary artery disease; Deep-learning based analysis Automated measurement of right and left ventricular diameters; Calculation and reporting of RV/LV ratio; Artificial intelligence algorithm for ventricle identification and measurement; Provides annotated images showing ventricular measurements; Generates summary PDF reports; Fully automated workflow, no user intervention required after scan completion; DICOM compliant input and output; Integration with standard reading environments (PACS)
Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CAC Software and Imbio RV/LV Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's Coronary Artery Calcification (CAC) software is designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest CT, supporting risk assessment for coronary artery disease. In contrast, Imbio RV/LV Software is an AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism.
The CAC Software analyzes non-contrast chest computed tomography (CT) scans to quantify coronary artery calcification. The RV/LV Software requires contrast-enhanced CT pulmonary angiogram (CTPA) images in DICOM format to measure ventricular diameters.
The CAC Software outputs the Agatston score, arterial age, calcified lesion mass and volume, along with 3D visualizations and annotated images. The RV/LV Software calculates and reports the RV/LV ratio and provides annotated images showing ventricular measurements, often summarized in PDF reports.
Imbio's CAC Software primarily supports Cardiology and Radiology specialties. The Imbio RV/LV Software extends its support to Cardiology, Pulmonology, and Radiology, given its utility in assessing pulmonary conditions.
AI Tool Finder
AI-powered search. Results may not be comprehensive.